July 7, 2026 · Hormone research in paediatrics · DOI: 10.1159/000553457

Growth hormone therapy in children born small for gestational age with persistent short stature (SGA-SS): Lessons learned from real-world international databases and directions for future research

Listen to this summary

This paper explores the efficacy and safety of recombinant human growth hormone (rhGH) therapy in children born small for gestational age with persistent short stature (SGA-SS), a condition affecting about 10% of this population. The authors highlight the variability in treatment response due to the heterogeneous causes of SGA-SS and emphasize the importance of integrating genetic insights and next-generation patient databases to develop more personalized treatment strategies. Future research directions aim to refine treatment regimens and improve long-term outcomes for affected children.

Sona Samvelyan, S Faisal Ahmed, Malika Alimussina, Aneta Kodytkova, Barbora Jirova, Shenali Anne Amaratunga, Jan Lebl

This is one of 33,000+ journals available on OSLR. Try it free for 14 days.

Free 14-day trial. 33,000+ journals. Cancel anytime.

14-day free trial. No commitment.

"Oslr has become part of my weekly routine on my day off. The clinical relevance of the summaries is outstanding — I'd rate it 9/10. Being able to consume research hands-free is a huge advantage for busy physicians."

Dr. Jennifer Thompson

Dr. Jennifer Thompson

Portland, OR

Stay current without falling behind

33,000+ journals. 3-minute audio summaries. Free for 14 days.

Download on the App StoreGet it on Google Play